Yale OCD Research Clinic
Christopher Pittenger, MD, PhD, is the current Director of the Yale OCD Research Clinic. He is an Assistant Professor of Psychiatry, Psychology, and in the Child Study Center at the Yale School of Medicine. The Yale OCD Research Clinic was founded in the mid-1980s by Wayne Goodman and Dennis Charney. It has been the site of some of the major advances in the biological understanding and pharmacological treatment of OCD, including the development of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the first trial of SSRI treatment of OCD, and the first trials of antipsychotic augmentation of SRI treatment. In recent years, we have investigated a new class of medications, glutamate-modulating agents, in the hope that they will provide a new treatment option for patients whose symptoms are refractory to proven psychological and pharmacological approaches. We see a limited number of clinical patients in consultation, but we are not able to be patients’ primary prescribers or therapists over an extended period of time; rather, patients work with us during their participation in a research protocol and for some appropriate period of time thereafter. Typically, patients continue with their current providers during participation in any of our studies.
We are funded by donations and research grants (including funding in the past from the IOCDF); therefore, all treatment received as party of a research program is provided at no cost. Based on demand, some clinical consultations may be available on a sliding scale.
IOCDF Professional Members at this Clinic
- Christopher Pittenger, MD, PhD